Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.06
-0.46 (-1.67%)
At close: Apr 28, 2026, 4:00 PM EDT
27.00
-0.06 (-0.22%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Assembly Biosciences stock have an average target of 44.2, with a low estimate of 38 and a high estimate of 50. The average target predicts an increase of 63.34% from the current stock price of 27.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $39 → $43 | Strong Buy | Maintains | $39 → $43 | +58.91% | Apr 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +84.77% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +84.77% | Dec 22, 2025 |
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +47.82% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +84.77% | Oct 14, 2025 |
Financial Forecast
Revenue This Year
7.14M
from 72.30M
Decreased by -90.12%
Revenue Next Year
52.72M
from 7.14M
Increased by 638.39%
EPS This Year
-2.88
from -0.55
EPS Next Year
-2.05
from -2.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 14.7M | 137.8M | ||||||
| Avg | 7.1M | 52.7M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -79.7% | 1,830.1% | ||||||
| Avg | -90.1% | 638.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.91 | 1.51 | ||||||
| Avg | -2.88 | -2.05 | ||||||
| Low | -4.08 | -5.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.